Patient-generated health data tracking platform Sanius Health is redefining care for patients with rare blood disorders by combining remote monitoring, predictive artificial intelligence (AI), and proactive care pathways with the aim of reducing hospital admissions and improving quality of life.

For conditions like sickle cell disease (SCD), early deterioration often goes unnoticed until hospitalisation. Sanius’s AI models analyse wearable device data and patient-reported outcomes – including hydration, sleep, fatigue, and pain – to generate daily risk scores. In SCD, these models can predict an oncoming vaso-occlusive crisis with up to 92% sensitivity, giving patients and clinicians a crucial window in which to intervene.

Orlando Agrippa, Founder and CEO of Sanius Health, said: “Healthcare for rare and chronic conditions has traditionally been reactive… At Sanius, we’re shifting that paradigm. By combining real-time patient data, predictive AI, and targeted care interventions, we can anticipate complications before they escalate and empower both patients and clinicians to act early.”

Sanius’s platform is also applied to multiple myeloma and chronic myeloid leukaemia, tracking disease progression and providing clinicians with actionable insights. Integrated into intuitive digital care pathways, the system supports early intervention, personalised treatment, and enhanced patient engagement.

“This is a fundamental shift in how we think about patient care… By anticipating complications and reducing emergency visits, our platform helps alleviate pressure on hospitals, optimises resources, and allows clinicians to focus on preventive care rather than repeated crisis management,” Agrippa added.

The ITIJ team recently explored issues caused by poor cybersecurity and what healthcare providers could do to address them.